Achieving the millennium development goals for health - Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries

被引:103
作者
Hogan, DR
Baltussen, R
Hayashi, C
Lauer, JA
Salomon, JA
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA
[3] Erasmus MC, Inst Med Technol Assessment, Rotterdam, Netherlands
[4] WHO, Strateg Informat & Res, Dept HIV AIDS, CH-1211 Geneva, Switzerland
[5] WHO, Costs Effectiveness Expenditure & Prior Setting T, Hlth Syst Financing Dept, CH-1211 Geneva, Switzerland
来源
BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7530期
关键词
D O I
10.1136/bmj.38643.368692.68
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS. Design Cost effectiveness analysis based on an epidemiological model. Setting Analyses undertaken for two regions classified using the WHO epidemiological grouping-Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality. Data sources Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database. Main outcome measures Costs per disability adjusted life year (DALY) averted in 2000 international dollars ($Int). Results In both regions interventions focused on mass media, education and treatment of sexually transmitted infections for female sex workers, amid treatment of sexually transmitted infections in the general population cost < $Int150 per DALY averted. Voluntary counselling and testing costs < $Int350 per DALY averted in both regions, while prevention of mother to child transmission costs < $Int50 per DALY averted in Afr-E but around $Int850 per DALY in Sear-D. School based education strategies and various antiretroviral treatment strategies cost between $Int500 and $Int5000 per DALY averted. Conclusions Reducing HIV transmission could be done most efficiently through mass media campaigns, interventions for sex workers and treatment of sexually transmitted infections where resources are most scarce. However, prevention of mother to child transmission, voluntary counselling and testing, and school based education would yield further health gains at higher budget levels and would be regarded as cost effective or highly cost effective based on standard international benchmarks. Antiretroviral therapy is at least as cost effective in improving population health as some of these interventions.
引用
收藏
页码:1431 / 1435
页数:7
相关论文
共 25 条
[1]  
[Anonymous], ANT DRUGS PREV MOTH
[2]   Where are the gaps? The effects of HIV-prevention interventions on behavioral change [J].
Bollinger, L ;
Cooper-Arnold, K ;
Stover, J .
STUDIES IN FAMILY PLANNING, 2004, 35 (01) :27-38
[3]   Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence [J].
Creese, A ;
Floyd, K ;
Alban, A ;
Guinness, L .
LANCET, 2002, 359 (9318) :1635-1642
[4]   The impact of HIV and AIDS on Africa's economic development [J].
Dixon, S ;
McDonald, S ;
Roberts, J .
BRITISH MEDICAL JOURNAL, 2002, 324 (7331) :232-234B
[5]   Achieving the millennium development goals for health - Methods to assess the costs and health effects of interventions for improving health in developing countries [J].
Evans, DB ;
Edejer, TTT ;
Adam, T ;
Lim, SS .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7525) :1137-1140
[6]   Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials [J].
Grosskurth, H ;
Gray, R ;
Hayes, R ;
Mabey, D ;
Wawer, M .
LANCET, 2000, 355 (9219) :1981-1987
[7]   IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASES ON HIV-INFECTION IN RURAL TANZANIA - RANDOMIZED CONTROLLED TRIAL [J].
GROSSKURTH, H ;
MOSHA, F ;
TODD, J ;
MWIJARUBI, E ;
KLOKKE, A ;
SENKORO, K ;
MAYAUD, P ;
CHANGALUCHA, J ;
NICOLL, A ;
KAGINA, G ;
NEWELL, J ;
MUGEYE, K ;
MABEY, D ;
HAYES, R .
LANCET, 1995, 346 (8974) :530-536
[8]   Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? [J].
Gutierrez, JP ;
Johns, B ;
Adam, T ;
Bertozzi, SM ;
Edejer, TTT ;
Greener, R ;
Hankins, C ;
Evans, DB .
LANCET, 2004, 364 (9428) :63-64
[9]  
GUTIERREZ JP, 2004, 15 INT AIDS C SAT SE
[10]  
GUTIERREZ JP, 2004, 15 IN AIDS C SAT SES